148 related articles for article (PubMed ID: 32994204)
21. Bevacizumab Induces Acute Hypoxia and Cancer Progression in Patients with Refractory Breast Cancer: Multimodal Functional Imaging and Multiplex Cytokine Analysis.
Ueda S; Saeki T; Osaki A; Yamane T; Kuji I
Clin Cancer Res; 2017 Oct; 23(19):5769-5778. PubMed ID: 28679773
[No Abstract] [Full Text] [Related]
22. Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model.
Ramezani S; Vousooghi N; Ramezani Kapourchali F; Yousefzadeh-Chabok S; Reihanian Z; Alizadeh AM; Khodayari S; Khodayari H
Life Sci; 2019 Dec; 239():116880. PubMed ID: 31678282
[TBL] [Abstract][Full Text] [Related]
23. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
[TBL] [Abstract][Full Text] [Related]
24. A Bayesian Approach to Eigenspectra Optoacoustic Tomography.
Olefir I; Tzoumas S; Yang H; Ntziachristos V
IEEE Trans Med Imaging; 2018 Sep; 37(9):2070-2079. PubMed ID: 29993865
[TBL] [Abstract][Full Text] [Related]
25. Photoacoustic Imaging as an Early Biomarker of Radio Therapeutic Efficacy in Head and Neck Cancer.
Rich LJ; Miller A; Singh AK; Seshadri M
Theranostics; 2018; 8(8):2064-2078. PubMed ID: 29721063
[TBL] [Abstract][Full Text] [Related]
26. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts.
Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L
J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775
[TBL] [Abstract][Full Text] [Related]
27. Tocilizumab inhibits IL-8 and the proangiogenic potential of triple negative breast cancer cells.
Alraouji NN; Aboussekhra A
Mol Carcinog; 2021 Jan; 60(1):51-59. PubMed ID: 33264466
[TBL] [Abstract][Full Text] [Related]
28. Quantitative In Vivo Monitoring of Hypoxia and Vascularization of Patient-Derived Murine Xenografts of Mantle Cell Lymphoma Using Photoacoustic and Ultrasound Imaging.
Keša P; Pokorná E; Grajciarová M; Tonar Z; Vočková P; Trochet P; Kopeček M; Jakša R; Šefc L; Klener P
Ultrasound Med Biol; 2021 Apr; 47(4):1099-1107. PubMed ID: 33455807
[TBL] [Abstract][Full Text] [Related]
29. Stem-like tumor cells involved in heterogeneous vasculogenesis in breast cancer.
Mao Y; Zhu L; Huang Z; Luo C; Zhou T; Li L; Wang G; Yang Z; Qi W; Yang X; Gao G
Endocr Relat Cancer; 2020 Jan; 27(1):23-39. PubMed ID: 31705798
[TBL] [Abstract][Full Text] [Related]
30. Model driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasis.
Mollard S; Ciccolini J; Imbs DC; El Cheikh R; Barbolosi D; Benzekry S
Oncotarget; 2017 Apr; 8(14):23087-23098. PubMed ID: 28416742
[TBL] [Abstract][Full Text] [Related]
31. 68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.
Kazmierczak PM; Todica A; Gildehaus FJ; Hirner-Eppeneder H; Brendel M; Eschbach RS; Hellmann M; Nikolaou K; Reiser MF; Wester HJ; Kropf S; Rominger A; Cyran CC
PLoS One; 2016; 11(12):e0168248. PubMed ID: 27992512
[TBL] [Abstract][Full Text] [Related]
32. Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer.
McKnight BN; Kim S; Boerner JL; Viola NT
Breast Cancer Res; 2020 Apr; 22(1):37. PubMed ID: 32295603
[TBL] [Abstract][Full Text] [Related]
33. The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer.
Inglis DJ; Lavranos TC; Beaumont DM; Leske AF; Brown CK; Hall AJ; Kremmidiotis G
Cancer Biol Ther; 2014; 15(11):1552-60. PubMed ID: 25482941
[TBL] [Abstract][Full Text] [Related]
34. Anti-angiogenic therapy affects the relationship between tumor vascular structure and function: A correlation study between micro-computed tomography angiography and dynamic contrast enhanced MRI.
Kim E; Kim J; Maelandsmo GM; Johansen B; Moestue SA
Magn Reson Med; 2017 Oct; 78(4):1513-1522. PubMed ID: 27888545
[TBL] [Abstract][Full Text] [Related]
35. Assessment of tumor oxygenation and its impact on treatment response in bevacizumab-treated recurrent glioblastoma.
Bonekamp D; Mouridsen K; Radbruch A; Kurz FT; Eidel O; Wick A; Schlemmer HP; Wick W; Bendszus M; Østergaard L; Kickingereder P
J Cereb Blood Flow Metab; 2017 Feb; 37(2):485-494. PubMed ID: 26861817
[TBL] [Abstract][Full Text] [Related]
36. Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation.
McGee MC; Hamner JB; Williams RF; Rosati SF; Sims TL; Ng CY; Gaber MW; Calabrese C; Wu J; Nathwani AC; Duntsch C; Merchant TE; Davidoff AM
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1537-45. PubMed ID: 20338480
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanisms.
Wagner J; Kline CL; Zhou L; Khazak V; El-Deiry WS
J Exp Clin Cancer Res; 2018 Jan; 37(1):11. PubMed ID: 29357916
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma.
Mao XG; Wang C; Liu DY; Zhang X; Wang L; Yan M; Zhang W; Zhu J; Li ZC; Mi C; Tian JY; Hou GD; Miao SY; Song ZX; Li JC; Xue XY
Oncotarget; 2016 Jul; 7(30):47808-47820. PubMed ID: 27329597
[TBL] [Abstract][Full Text] [Related]
39. Apelin as a marker for monitoring the tumor vessel normalization window during antiangiogenic therapy.
Zhang L; Takara K; Yamakawa D; Kidoya H; Takakura N
Cancer Sci; 2016 Jan; 107(1):36-44. PubMed ID: 26475217
[TBL] [Abstract][Full Text] [Related]
40. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
